Lilly profit plunges as cheaper generics take toll
October 23, 2014 at 06:50 AM EDT
Oct 23 (Reuters) - Eli Lilly and Co said its quarterly earnings plunged 58 percent, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its earlier full-year profit forecast.